Polycomb group proteins are key regulators of keratinocyte function

Journal of Investigative Dermatology

Volumn 131, Issue 2, 2011, Pages 295-301

  Eckert, Richard L ^a   Adhikary, Gautam ^a   Rorke, Ellen A ^a   Chew, Yap Ching ^a   Balasubramanian, Sivaprakasam ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BMI1 PROTEIN; POLYCOMB GROUP PROTEIN;

APOPTOSIS; CELL AGING; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CELL SURVIVAL; EPIGENETICS; GENE EXPRESSION; HISTONE MODIFICATION; HUMAN; KERATINOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SKIN CARCINOGENESIS; STEM CELL; TRANSCRIPTION REGULATION;

EID: 78651402346     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2010.318     Document Type: Review

References (77)

1. Ahmad N, Mukhtar H (1999) Green tea polyphenols and cancer: biologic mechanisms and practical implications. Nutr Rev 57:78-83
2. Aoto T, Saitoh N, Sakamoto Y et al. (2008) Polycomb group protein-associated chromatin is reproduced in post-mitotic G1 phase and is required for S phase progression. J Biol Chem 283:18905-15
3. Bachmann IM, Halvorsen OJ, Collett K et al. (2006) EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. J Clin Oncol 24:268-73
4. Bachmann IM, Puntervoll HE, Otte AP etal. (2008) Loss of BMI-1 expression is associated with clinical progress of malignant melanoma. Mod Pathol 21:583-90
5. Balasubramanian S, Adhikary G, Eckert RL (2010) The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival. Carcinogenesis 31:496-503
6. Balasubramanian S, Lee K, Adhikary G et al. (2008) The Bmi-1 polycomb group gene in skin cancer: regulation of function by (-)-epigallocate-chin-3- gallate. Nutr Rev 66(Suppl 1):S65-8
7. Barrandon Y, Green H (1987) Three clonal types of keratinocyte with different capacities for multiplication. Proc Natl Acad Sci USA 84:2302-6
8. Bracken AP, Kleine-Kohlbrecher D, Dietrich N et al. (2007) The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev 21:525-30
9. Breuer RH, Snijders PJ, Smit EF et al. (2004) Increased expression of the EZH2 polycomb group gene in BMI-1-positive neoplastic cells during bronchial carcinogenesis. Neoplasia 6:736-43
10. Brown JL, Fritsch C, Mueller J et al. (2003) The Drosophila pho-like gene encodes a YY1-related DNA binding protein that is redundant with pleiohomeotic in homeotic gene silencing. Development 130:285-94
11. Brown JL, Mucci D, Whiteley M etal. (1998) The Drosophila Polycomb group gene pleiohomeotic encodes a DNA binding protein with homology to the transcription factor YY1. Mol Cell 1:1057-64
12. Brunner M, Thurnher D, Pammer J et al. (2008) Expression of VEGF-A/C, VEGF-R2, PDGF-alpha/beta, c-kit, EGFR, Her-2/Neu, Mcl-1 and Bmi-1 in Merkel cell carcinoma. Mod Pathol 21:876-84
13. Cao R, Tsukada Y, Zhang Y (2005) Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing. Mol Cell 20:845-54
14. Cao R, Zhang Y (2004) SUZ12 is required for both the histone methyl-transferase activity and the silencing function of the EED-EZH2 complex. Mol Cell 15:57-67
15. Caretti G, Di PM, Micales B et al. (2004) The Polycomb Ezh2 methyltransfer-ase regulates muscle gene expression and skeletal muscle differentiation. Genes Dev 18:2627-38
16. Cohen KJ, Hanna JS, Prescott JE et al. (1996) Transformation by the Bmi-1 oncoprotein correlates with its subnuclear localization but not its transcriptional suppression activity. Mol Cell Biol 16:5527-35
17. Cordisco S, Maurelli R, Bondanza S et al. (2010) Bmi-1 reduction plays a key role in physiological and premature aging of primary human keratinocytes. J Invest Dermatol 130:1048-62
18. + somatic cell types. Stem Cells 27:1388-99
19. Datta S, Hoenerhoff MJ, Bommi P et al. (2007) Bmi-1 cooperates with H-Ras to transform human mammary epithelial cells via dysregulation of multiple growth-regulatory pathways. Cancer Res 67:10286-95
20. Dimri GP, Martinez JL, Jacobs JJ et al. (2002) The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells. Cancer Res 62:4736-45
21. Eckert RL, Crish JF, Robinson NA (1997) The epidermal keratinocyte as a model for the study of gene regulation and cell differentiation. Physiol Rev 77:397-424
22. Endoh M, Endo TA, Endoh T et al. (2008) Polycomb group proteins Ring1A/B are functionally linked to the core transcriptional regulatory circuitry to maintain ES cell identity. Development 135:1513-24
23. Ezhkova E, Pasolli HA, Parker JS et al. (2009) Ezh2 orchestrates gene expression for the stepwise differentiation of tissue-specific stem cells. Cell 136:1122-35
24. Fischle W, Wang Y, Jacobs SA et al. (2003) Molecular basis for the discrimination of repressive methyl-lysine marks in histone H3 by Polycomb and HP1 chromodomains. Genes Dev 17:1870-81
25. Haga K, Ohno S, Yugawa T et al. (2007) Efficient immortalization of primary human cells by p16INK4a-specific short hairpin RNA or Bmi-1, combined with introduction of hTERT. Cancer Sci 98:147-54
26. Hatano A, Matsumoto M, Higashinakagawa T et al. (2010) Phosphorylation of the chromodomain changes the binding specificity of Cbx2 for methylated histone H3. Biochem Biophys Res Commun 397:93-9
27. Haupt Y, Bath ML, Harris AW et al. (1993) bmi-1 transgene induces lymphomas and collaborates with myc in tumorigenesis. Oncogene 8:3161-4
28. Iwama A, Oguro H, Negishi M et al. (2004) Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product Bmi-1. Immunity 21:843-51
29. Jacobs JJ, Kieboom K, Marino S et al. (1999a) The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397:164-8
30. Jacobs JJ, Scheijen B, Voncken JW et al. (1999b) Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev 13:2678-90
31. Jacobs JJ, Van Lohuizen M (2002) Polycomb repression: from cellular memory to cellular proliferation and cancer. Biochim Biophys Acta 1602:151-61
32. Kim JH, Yoon SY, Jeong SH et al. (2004a) Overexpression of Bmi-1 oncoprotein correlates with axillary lymph node metastases in invasive ductal breast cancer. Breast 13:383-8
33. Kim JH, Yoon SY, Kim CN et al. (2004b) The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF proteins. Cancer Lett 203:217-24
34. Kirmizis A, Bartley SM, Kuzmichev A et al. (2004) Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27. Genes Dev 18:1592-605
35. Krimpenfort P, Quon KC, Mooi WJ et al. (2001) Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice. Nature 413:83-6
36. Krishnamurthy J, Torrice C, Ramsey MR et al. (2004) Ink4a/Arf expression is a biomarker of aging. J Clin Invest 114:1299-307
37. Kuzmichev A, Margueron R, Vaquero A et al. (2005) Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation. Proc Natl Acad Sci USA 102:1859-64
38. Lan F, Nottke AC, Shi Y (2008) Mechanisms involved in the regulation of histone lysine demethylases. Curr Opin Cell Biol 20:316-25
39. Lee K, Adhikary G, Balasubramanian S et al. (2008) Expression of Bmi-1 in epidermis enhances cell survival by altering cell cycle regulatory protein expression and inhibiting apoptosis. J Invest Dermatol 128:9-17
40. Lessard J, Sauvageau G (2003) Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423:255-60
41. Leung C, Lingbeek M, Shakhova O et al. (2004) Bmi1 is essential for cerebellar development and is overexpressed in human medulloblasto-mas. Nature 428:337-41
42. Levine SS, King IF, Kingston RE (2004) Division of labor in polycomb group repression. Trends Biochem Sci 29:478-85
43. Li Z, Cao R, Wang M et al. (2006) Structure of a Bmi-1-Ring1B polycomb group ubiquitin ligase complex. J Biol Chem 281:20643-9
44. Lowe SW, Sherr CJ (2003) Tumor suppression by Ink4a-Arf: progress and puzzles. Curr Opin Genet Dev 13:77-83
45. Mihaly J, Mishra RK, Karch F (1998) A conserved sequence motif in Polycomb-response elements. Mol Cell 1:1065-6
46. Mihic-Probst D, Kuster A, Kilgus S et al. (2007) Consistent expression of the stem cell renewal factor BMI-1 in primary and metastatic melanoma. Int J Cancer 121:1764-70
47. Molofsky AV, Pardal R, Iwashita T et al. (2003) Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 425:962-7
48. Mosammaparast N, Shi Y (2010) Reversal of histone methylation: biochemical and molecular mechanisms of histone demethylases. Annu Rev Biochem 79:155-79
49. Nottke A, Colaiacovo MP, Shi Y (2009) Developmental roles of the histone lysine demethylases. Development 136:879-89
50. Orlando V (2003) Polycomb, epigenomes, and control of cell identity. Cell 112:599-606
51. Pandey RR, Mondal T, Mohammad F et al. (2008) Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation. Mol Cell 32:232-46
52. Park IK, Qian D, Kiel M et al. (2003) Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 423:302-5
53. Pasini D, Bracken AP, Jensen MR et al. (2004) Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity. EMBO J 23:4061-71
54. Raaphorst FM, Meijer CJ, Fieret E et al. (2003) Poorly differentiated breast carcinoma is associated with increased expression of the human polycomb group EZH2 gene. Neoplasia 5:481-8
55. Raman JD, Mongan NP, Tickoo SK et al. (2005) Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder. Clin Cancer Res 11:8570-6
56. Reinisch CM, Uthman A, Erovic BM et al. (2007) Expression of BMI-1 in normal skin and inflammatory and neoplastic skin lesions. J Cutan Pathol 34:174-80
57. Ressler S, Bartkova J, Niederegger H et al. (2006) p16INK4A is a robust in vivo biomarker of cellular aging in human skin. Aging Cell 5:379-89
58. Rinn JL, Kertesz M, Wang JK et al. (2007) Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129:1311-23
59. Saramaki OR, Tammela TL, Martikainen PM et al. (2006) The gene for polycomb group protein enhancer of zeste homolog 2 (EZH2) is amplified in late-stage prostate cancer. Genes Chromosomes Cancer 45:639-45
60. Sen GL, Webster DE, Barragan DI et al. (2008) Control of differentiation in a self-renewing mammalian tissue by the histone demethylase JMJD3. Genes Dev 22:1865-70
61. Serrano M, Hannon GJ, Beach D (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366:704-7
62. Sharpless NE, Bardeesy N, Lee KH et al. (2001) Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature 413:86-91
63. Shaw T, Martin P (2009) Epigenetic reprogramming during wound healing: loss of polycomb-mediated silencing may enable upregulation of repair genes. EMBO Rep 10:881-6
64. Silva J, Garcia JM, Pena C et al. (2006) Implication of polycomb members Bmi-1, Mel-18, and Hpc-2 in the regulation of p16INK4a, p14ARF, h-TERT, and c-Myc expression in primary breast carcinomas. Clin Cancer Res 12:6929-36
65. Simon JA, Kingston RE (2009) Mechanisms of polycomb gene silencing: knowns and unknowns. Nat Rev Mol Cell Biol 10:697-708
66. Simon JA, Lange CA (2008) Roles of the EZH2 histone methyltransferase in cancer epigenetics. Mutat Res 647:21-9
67. Sparmann A, Van Lohuizen M (2006) Polycomb silencers control cell fate, development and cancer. Nat Rev Cancer 6:846-56
68. Stock JK, Giadrossi S, Casanova M et al. (2007) Ring1-mediated ubiquitina-tion of H2A restrains poised RNA polymerase II at bivalent genes in mouse ES cells. Nat Cell Biol 9:1428-35
69. Sudo T, Utsunomiya T, Mimori K et al. (2005) Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma. Br J Cancer 92:1754-8
70. Valk-Lingbeek ME, Bruggeman SW, Van LM (2004) Stem cells and cancer; the polycomb connection. Cell 118:409-18
71. Varambally S, Dhanasekaran SM, Zhou M et al. (2002) The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419:624-9
72. Vonlanthen S, Heighway J, Altermatt HJ et al. (2001) The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression. Br J Cancer 84:1372-6
73. Wang L, Brown JL, Cao R et al. (2004) Hierarchical recruitment of polycomb group silencing complexes. Mol Cell 14:637-46
74. Wang Q, Li WL, You P et al. (2009) Oncoprotein BMI-1 induces the malignant transformation of HaCaT cells. J Cell Biochem 106:16-24
75. Weber JD, Taylor LJ, Roussel MF et al. (1999) Nucleolar Arf sequesters Mdm2 and activates p53. Nat Cell Biol 1:20-6
76. Yu Q, Su B, Liu D et al. (2007) Antisense RNA-mediated suppression of Bmi-1 gene expression inhibits the proliferation of lung cancer cell line A549. Oligonucleotides 17:327-35
77. Zhou W, Zhu P, Wang J et al. (2008) Histone H2A monoubiquitination represses transcription by inhibiting RNA polymerase II transcriptional elongation. Mol Cell 29:69-80